Target intelligence / Profile preview

Lotrafilcon A

Molecular classification
Polymer, Silicone hydrogel, Fluoro-silicone hydrogel
01

Overview

Lotrafilcon A is a high-performance silicone hydrogel material primarily used in the manufacturing of soft contact lenses, such as the Focus Night & Day and Air Optix brands (FDA PMA P980006). It is a biphasic copolymer consisting of a fluoro-silicone phase that provides exceptionally high oxygen permeability (Dk of 140) and a hydrogel phase that facilitates the transport of water and ions (Contact Lens Spectrum, 2008). This unique structure allows the material to maintain corneal health by ensuring adequate oxygenation, even during extended or continuous wear for up to 30 nights. Beyond vision correction for refractive errors like myopia and hyperopia, Lotrafilcon A is frequently employed as a therapeutic bandage contact lens to promote epithelial healing and provide pain relief in conditions such as corneal erosions, bullous keratopathy, and post-surgical recovery (NIH, 2003; NIH, 2005). As a synthetic polymer, it is not a biological target like a receptor or enzyme but rather a medical device component that interacts physically with the ocular surface and tear film. While it does not have a biochemical mechanism of action, its physical properties are critical for its clinical efficacy in both refractive and therapeutic applications.

Other names
Silicone hydrogel materialLotrafilcon A polymerFocus Night & Day materialAir Optix material
02

Mechanism of action

Lotrafilcon A acts as a physical refractive medium to focus light on the retina and provides a high-oxygen-permeable barrier for corneal protection and healing.

03

Biological functions

Vision correctionOxygen transportCorneal protectionRefractive correction
04

Disease associations

MyopiaHyperopiaAstigmatismPresbyopiaCorneal erosionBullous keratopathyCorneal edema
05

Safety considerations

Microbial keratitisCorneal ulcerGiant papillary conjunctivitisCorneal neovascularizationEpithelial microcysts
06

Interacting drugs

Ophthalmic lubricants

3 more in the full profile.

Beyond the preview

Go deeper on Lotrafilcon A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lotrafilcon A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call